What is the Projected CAGR value of the Nanomedicine Market?
Global Nanomedicine market is expected to grow at a CAGR of 8.74% during the forecast period 2024-2031.
Who are the key players in Nanomedicine Market?
Key players are Pfizer Inc., CytImmune Sciences, Ablynx (Sanofi S.A.), Genentech Inc., Mallinckrodt, Moderna Inc., Janssen Pharmaceutical, Amgen Inc., Merck and Teva Pharmaceuticals among others.